In a trial, the newly approval urethral stent provided significant and durable relief of BPH-related LUTS over 12 months. The FDA has approved the ProVee® System for treatment of benign prostatic ...
A trial of a permanent prostatic urethral stent for treatment of BPH demonstrated early success. A novel prostatic urethral stent can reduce lower urinary tract symptoms (LUTS) in men with benign ...
SAN FRANCISCO, CA – SEPTEMBER 21, 2009 – A new type of sirolimus-eluting stent (SES) successfully showed significantly greater neointimal suppression than the paclitaxel-eluting stent (PES) with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results